DOP78: Efficacy of ozanimod by patient response trajectory subgroups identified using group-based trajectory modelling: a post hoc analysis of the phase 3 True North studyECCO'24Year: 2024
Authors: Schreiber, S.W.(1)*;Feagan, B.G.(2);Sands, B.E.(3);Rieder, F.(4);Torres, J.(3,5,6,7);Liu, Z.(8);Jain, A.(8);Poehler, A.M.(9);Wu, H.(8);Osterman, M.T.(8);Abreu, M.T.(10);Dulai, P.S.(11);
(1)Department of Internal Medicine I- University Hospital Schleswig-Holstein- Kiel University, Internal Medicine I, Kiel, Germany;(2)Robarts Research Institute- Western University, Gastroenterology, London, Canada;(3)Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States;(4)Department of Gastroenterology- Hepatology- and Nutrition- Digestive Disease Institute- Cleveland Clinic, Gastroenterology- Hepatology- and Nutrition, Cleveland, United States;(5)Division of Gastroenterology- Hospital da Luz, Gastroenterology, Lisbon, Portugal;(6)Division of Gastroenterology- Hospital Beatriz Ângelo, Gastroenterology, Lisbon, Portugal;(7)Faculdade de Medicina- Universidade de Lisboa, Gastroenterology, Lisbon, Portugal;(8)Bristol Myers Squibb, n/a, Princeton, United States;(9)Bristol Myers Squibb, n/a, Munich, Germany;(10)University of Miami Miller School of Medicine, Gastroenterology, Miami, United States;(11)Feinberg School of Medicine- Northwestern University, Gastroenterology and Hepatology, Chicago, United States;
DOP79: Promising efficacy of biologicals and small molecules for microscopic colitis: results from a large real-life multicenter cohortECCO'24Year: 2024
Authors: Verstockt., B.(1,2)*;Taelman, T.(1);Vavricka, S.R.(3);Zabana, Y.(4);Lenfant, M.(1);Macaigne, G.(5);Maillard, M.H.(6,7);Savarino, E.(8);Teich, N.(9);Kiudelis, V.(10);de la Revilla Negro, J.(11);Ribaldone, D.G.(12);Barreiro-de Acosta, M.(13);Wildt, S.(14);Rivière, P.(15);Fumery, M.(16);Truyens, M.(17);Amiot, A.(18);Marsal, J.(19);Levartovsky, A.(20);Vieujean, S.(21);Somers, M.(22);Cremer, A.(23);Lutakov, I.(24);Cohen, N.A.(25);Dewit, S.(26);Bajer, L.(27);Rahier, J.F.(28);Backman, A.S.(29,30);Nancey, S.(31);Choden, T.(32);Van Dongen, J.(33);Münch, A.(34);Julsgaard, M.(35,36);
(1)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(2)KU Leuven, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(3)University Hospital Zurich, Department of Gastroenterology and Hepatology, Zurich, Switzerland;(4)ospital Universitari Mútua Terrassa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Department of Gastroenterology, Barcelona, Spain;(5)Centre Hospitalier de Marne-la-Vallee, Hepatogastroenterology Unit, Jossigny, France;(6)Lausanne Digestive Disease Center, Gastroenterology, Lausanne, Switzerland;(7)Lausanne University Hospital, Service of Gastroenterology and Hepatology, Lausanne, Switzerland;(8)University of Padua, Department of Surgery- Oncology and Gastroenterology, Padua, Italy;(9)Internistische Gemeinschaftspraxis, Gastroenterology, Leipzig, Germany;(10)Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Department of Gastroenterology, Kaunas, Lithuania;(11)Addenbrookes Hospital. Cambridge University Hospitals, Department of Gastroenterology, Cambridge, United Kingdom;(12)University of Turin, Department of Medical Sciences, Turin, Italy;(13)University Hospital Santiago De Compostela CHUS, Department of Gastroenterology- IBD Unit, Santiago De Compostela, Spain;(14)Hvidovre Hospital- University Hospital of Copenhagen, Gastrounit, Copenhagen, Denmark;(15)CHU de Bordeaux, Service d’hépato-gastroentérologie et oncologie digestive, Bordeaux, France;(16)Amiens University Hospital, Department of gastroenterology, Amiens, France;(17)University Hospital Ghent, Department of Gastroenterology, Ghent, Belgium;(18)Bicetre university hospital- Paris Saclay university, Department of gastroentérology, le Kremlin Bicêtre, France;(19)Skane University Hospital, Department of Gastroenterology, Lund, Sweden;(20)Sheba Medical Center, Department of Gastroenterology, Tel-Hashomer, Israel;(21)University Hospital CHU of Liège, Hepato-Gastroenterology and Digestive Oncology, Liège, Belgium;(22)University Hospital Antwerp, Department of Gastroenterology and Hepatology, Antwerp, Belgium;(23)Erasme University Hospital, Department of Gastroenterology and Hepatology, Brussels, Belgium;(24)University Hospital “Queen Joanna-ISUL” Sofia- Medical University Sofia, Clinical Center of Gastroenterology, Sofia, Bulgaria;(25)Tel Aviv Medical Center, IBD Center- Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel;(26)Noorderhart Mariaziekenhuis, Department of Gastroenterology, Pelt, Belgium;(27)Institute for Clinical and Experimental Medicine, Department of Gastroenterology and Hepatology, Prague, Czech Republic;(28)Université catholique de Louvain- CHU UCL Namur, Department of Gastroenterology and Hepatology, Yvoir, Belgium;(29)Ersta Hospital, Department of Internal Medicine, Stockholm, Sweden;(30)Huddinge- Karolinska Institutet, Unit of gastroenterology-Department of Medicine, Stockholm, Sweden;(31)Lyon-Sud hospital- Hospices Civils de Lyon, Department of Gastroenterology, Pierre-Bénite, France;(32)University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, United States;(33)AZ Sint Maarten, Department of Gastroenterology, Mechelen, Belgium;(34)Linköping University, Department of Gastroenterology and Hepatology, Linköping, Sweden;(35)Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus, Denmark;(36)Center for Molecular Prediction of Inflammatory Bowel Disease PREDICT- Aalborg University, Department of Clinical Medicine, Copenhagen, Denmark;
DOP80: Prevalence and factors associated with Inflammatory Bowel Disease (IBD) activity during pregnancy: updated data from the DUMBO RegistryECCO'24Year: 2024
Authors: Chaparro, M.(1)*;García Donday, M.(1);Núñez Ortiz, A.(2);Calviño Suarez, C.(3);Rubio Iturria, S.(4);Sánchez Azofra, M.(5);Calvo Moya, M.(6);Pérez-Martínez, I.(7);Fernández-Clotet, A.(8);Alfambra, E.(9);Marín Pedrosa, S.(10);Diz-Lois Palomares, M.T.(11);Hernandez, V.(12);Ruiz-Cerulla, A.(13);Casanova, M.J.(1);Rivero, M.(14);Huguet, J.M.(15);Vicente Lidón, R.(16);Árias García, L.(17);Guerra, I.(18);Hervías Cruz, D.(19);Gutiérrez Casbas, A.(20);Bejarano, A.(21);Camargo Camero, R.(22);Rodríguez-Lago, I.(23);Aguas, M.(24);De Jorge Turrión, M.Á.(25);Masedo Gonzalez, Á.(26);López Serrano, P.(27);Valldosera Gomis, G.(28);Ceballos, D.(29);Bujanda, L.(30);Molina Arriero, G.(31);Vega Villaamil, P.(32);Van Domselaar , M.(33);Boscá Watts, M.M.(34);Lucendo, A.J.(35);Zúñiga de Mora-Figueroa, B.(36);Busquets, D.(37);Gisbert, J.P.(1);
(1)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-Princesa- Universidad Autónoma de Madrid UAM- and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Gastroenterology Department, Madrid, Spain;(2)Hospital Universitario Virgen del Rocío, Gastroenterology Department, Sevilla, Spain;(3)Complexo Hospitalario Universitario de Santiago de Compostela, Gastroenterology Department, Santiago de Compostela, Spain;(4)Hospital Universitario de Navarra, Gastroenterology Department, Navarra, Spain;(5)Hospital Universitario La Paz. Grupo de enfermedades inmunomediadas gastrointestinales y otras patologías digestivas. Instituto de Investigación Sanitaria del Hospital Universitario La Paz – IdiPAZ., Gastroenterology Department, Madrid, Spain;(6)Hospital Universitario Puerta de Hierro Majadahonda, Gastroenterology Department, Majadahonda, Spain;(7)Hospital Universitario Central de Asturias. Diet- Microbiota and Health Group. Instituto de Investigación Sanitaria del Principado de Asturias ISPA, Gastroenterology Department, Oviedo, Spain;(8)Hospital Universitario Clinic I Provincial. Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas CIBERehd. Institut d@E@Investigacions Biomèdiques August Pi i Sunyer IDIBAPS, Gastroenterology Department, Barcelona, Spain;(9)Hospital Clínico Universitario Lozano Blesa. Fundación del Instituto de Investigación Sanitaria de Aragón IIS Aragón, Gastroenterology Department, Zaragoza, Spain;(10)Hospital Universitario Reina Sofía de Córdoba, Gastroenterology Department, Córdoba, Spain;(11)Complexo Hospitalario Universitario de A Coruña, Gastroenterology Department, A Coruña, Spain;(12)Hospital Álvaro Cunqueiro. Instituto de Investigación Sanitaria Galicia Sur IIS Galicia Sur. SERGAS-UVIGO., Gastroenterology Department, Vigo, Spain;(13)Hospital Universitario de Bellvitge, Gastroenterology Department, L’Hospitalet de Llobregat., Spain;(14)Hospital Universitario Marqués de Valdecilla e Instituto de Investigación IDIVAL, Gastroenterology Department, Santander, Spain;(15)Hospital General Universitario de Valencia, Gastroenterology Department, Valencia, Spain;(16)Hospital Universitario Miguel Servet, Gastroenterology Department, Zaragoza, Spain;(17)Hospital Universitario de Burgos, Gastroenterology Department, Burgos, Spain;(18)Hospital Universitario de Fuenlabrada e Instituto de Investigación Hospital Universitario La Paz IdiPAZ, Gastroenterology Department, Madrid, Spain;(19)Hospital General de Ciudad Real, Gastroenterology Department, Ciudad Real, Spain;(20)Hospital General Universitario Dr Balmis de Alicante- ISABIAL. CIBEREHD, Gastroenterology Department, Alicante, Spain;(21)Hospital Universitario Juan Ramón Jimenez, Gastroenterology Department, Huelva, Spain;(22)Hospital Universitario Virgen de La Victoria, Gastroenterology Department, Málaga, Spain;(23)Hospital Universitario de Galdakao- Biobizkaia Health Research Institute, Gastroenterology Department, Galdakao, Spain;(24)La Fe University Hospital- Valencia: IISLaFe Investigación del Instituto de Investigación Sanitaria La Fe, Gastroenterology Department, Valencia, Spain;(25)Hospital Universitario de Cabueñes, Department of Gastroenterology, Gijón, Spain;(26)Hospital Universitario 12 de Octubre, Gastroenterology Department, Madrid, Spain;(27)Hospital Universitario Fundación Alcorcón, Gastroenterology Department, Madrid, Spain;(28)Hospital Univeristari Joan XXIII, Gastroenterology Department, Tarragona, Spain;(29)Hospital Universitario de Gran Canaria “Dr. Negrín”, Gastroenterology Department, Las Palmas de Gran Canaria, Spain;(30)Bioodonostia Health Research Institute - Donostia University Hospital- Universidad del País Vasco UPV/EHU- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology Department, San Sebastián, Spain;(31)Complejo Hospitalario Universitario de Ferrol, Gastroenterology Department, Ferrol, Spain;(32)Complexo Hospitalario Universitario de Ourense, Gastroenterology Department, Ourense, Spain;(33)Hospital Universitario de Torrejón. Universidad Francisco de Vitoria, Gastroenterology Department, Torrejón, Spain;(34)Hospital Clínico Universitario de Valencia, Gastroenterology Department, Valencia, Spain;(35)Hospital General de Tomelloso. Instituto de Investigación Sanitaria Princesa. Instituto de Investigación Sanitaria de Castilla-La Mancha IDISCAM and CIBEREHD, Gastroenterology Department, Tomelloso, Spain;(36)Hospital Clínico Universitario San Cecilio, Gastroenterology Department, Granada, Spain;(37)Hospital Universitari de Girona Trueta, Gastroenterology Department, Girona, Spain;on behalf of DUMBO study group of GETECCU
DOP81: Rosnilimab, a novel PD-1 agonist monoclonal antibody, reduces T cell proliferation, inflammatory cytokine secretion, and PD-1high expressing CD4 and CD8 T cells: Results from a Phase 1 healthy volunteer clinical trialECCO'24Year: 2024
Authors: Luu, K.(1);Dahl, M.(2);Hare, E.(2);Sibley, C.(1)*;Lizzul, P.(1);Randazzo, B.(1);
(1)AnaptysBio- Inc, Clinical, San Diego, United States;(2)AnaptysBio- Inc, Research, San Diego, United States;
DOP83: Intestinal epithelium-specific deletion of the Aryl hydrocarbon Receptor (AhR) reduces intestinal Tight Junction permeability thereby hindering homeostatic antigen sampling and tolerogenic immune responses.ECCO'24Year: 2024
Authors: Saha, K.(1)*;Ganapathy, A.S.(1);Arumugam, P.(1);Wang, A.(1);Harris, L.(2);Yochum, G.(2);Koltun, W.(2);Nighot, M.(1);Nighot, P.(1);
(1)Penn State College of Medicine, Division of Gastroenterology and Hepatology- Department of Medicine, Hershey, United States;(2)Penn State College of Medicine, Division of colon and Rectal Surgery- Department of Surgery, Hershey, United States;
DOP84: Colonic CD4+ T cell senescence is implicated in the progression of experimental colitis in aged miceECCO'24Year: 2024
Authors: Zhang, Y.(1)*;Xu, J.(1);Zhang, Y.(1);Ke, Z.(1);Fang, X.(1);Lin, Y.(1);Liu, Y.(1);
(1)Peking University People@E@s Hospital, Gastroenterology, Beijing, China;
DOP85: An anti-fibrotic role for eosinophils in a DSS colitis RAG-/- and an in vitro co-culture modelECCO'24Year: 2024
Authors: Jacobs, I.(1,2)*;Deleu, S.(2);Cremer, J.(1);Dilissen, E.(1);De Hertogh, G.(3);Martens, T.(4);Vanden Berghe, P.(4);Vermeire, S.(2,5);Breynaert, C.(1,6);Vanuytsel, T.(2,5);Verstockt, B.(2,5);
(1)KU Leuven, Department of Microbiology- Immunology and Transplantation, Leuven, Belgium;(2)KU Leuven, Department of Chronic Diseases and Metabolism- Translational Research Center for Gastrointestinal Disorders TARGID, Leuven, Belgium;(3)University Hospitals Leuven, Department of Imaging and Pathology, Leuven, Belgium;(4)KU Leuven, Cell and tissue Imaging Core, Leuven, Belgium;(5)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(6)University Hospitals Leuven, Department of General Internal Medicine, Leuven, Belgium;
DOP86: FOod Additives on the Mucosal barrier study (FOAM): Effect of five emulsifiers on inflammation, intestinal permeability, and the microbiome: preliminary results.ECCO'24Year: 2024
Authors: Wellens, J.(1,2)*;Vanderstappen, J.(1);Hoekx, S.(1);Vissers, E.(2);Luppens, M.(1);Raes, J.(3,4);Verstockt, B.(1,5);Ferrante, M.(1,2);Verbeke, K.(2);Matthys, C.(6,7);Vermeire, S.(1,2);Sabino, J.(1,2);
(1)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(2)Translational Research Center for Gastrointestinal Disorders TARGID- KU Leuven, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(3)Rega Institute- KU Leuven, Microbiology- Immunology and Transplantation Department, Leuven, Belgium;(4)Vlaams instituut voor biotechnologie VIB, Center For Microbiology, Leuven, Belgium;(5)Translational Research Center for Gastrointestinal Disorders TARGID, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(6)Clinical and Experimental Endocrinology- KU Leuven, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(7)University Hospitals Leuven, Department of Endocrinology, Leuven, Belgium;
DOP87: Characterization of pathologic fibroblast and macrophage cell populations in colonic Crohn’s Disease with spatial transcriptomics.ECCO'24Year: 2024
Authors: Gudiño, V.(1,2)*;Acera, M.(3);Corraliza, A.M.(1,2);Garrido-Trigo, A.(1,2);Sanzo, Á.(1,2);Heyn, H.(4);Mereu, E.(3);Salas, A.(1,2);
(1)Institut d’Investigacions Biomèdiques August Pi i Sunyer FCRB-IDIBAPS, Inflammatory Bowel Disease Unit, Barcelona, Spain;(2)Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Ciberehd, Madrid, Spain;(3)Josep Carreras Leukaemia Research Institute IJC, Cellular systems genomics, Barcelona, Spain;(4)National Centre for Genomic Analysis CNAG, Single cell genomics, Barcelona, Spain;
DOP88: Lipids drive myofibroblast activation and the epithelial-mesenchymal transition process in Crohn’s Disease.ECCO'24Year: 2024
Authors: Rizzo, G.(1)*;Wozny, M.(2);Pineda Chavez, S.E.(2);Mori, G.(1);Carriles Linares, A.(2);Morosi, L.(3,4);Martano, G.(4,5);Ghisletti, S.M.L.(6);Gandolfi, F.(6);Vallelonga, V.(6);Loy, L.(7);Bezzio, C.(7);Spaggiari, P.(8);Dal Buono, A.(7);Gabbiadini, R.(7);Carvello, M.(9);Spinelli, A.(2);Repici, A.(2,10);Armuzzi, A.(2,7);Vetrano, S.(1,2);
(1)IRCCS Humanitas Research Hospital, Laboratory of Gastrointestinal Immunopathology- Department of Gastroenterology, Rozzano- Milan, Italy;(2)Humanitas University, Department of Biomedical Sciences, Pieve Emanuele- Milan, Italy;(3)IRCCS Humanitas Research Hospital, Laboratory of Cancer Pharmacology, Rozzano- Milan, Italy;(4)IRCCS Humanitas Research Hospital, Metabolomics Unit, Rozzano- Milan, Italy;(5)CNR, Institute of Neuroscience, Milan, Italy;(6)European Institute of Oncology IEO IRCCS, Department of Experimental Oncology, Milan, Italy;(7)IRCCS Humanitas Research Hospital, IBD Unit- Department of Gastroenterology, Rozzano- Milan, Italy;(8)Humanitas Clinical and Research Center-IRCCS, Department of Pathology, Rozzano- Milan, Italy;(9)IRCCS Humanitas Research Hospital, Colon and Rectal Surgery Unit, Rozzano- Milan, Italy;(10)Humanitas Clinical and Research Center-IRCCS, Digestive Endoscopy Unit- Department of Gastroenterology, Rozzano- Milan, Italy;
N02: Inflammatory bowel disease patients with impaired quality of life on biologic therapy benefit from the support of an IBD nurse specialist: Results of a randomized controlled trial in Germany (IBDBIO-ASSIST study) - The IBD nurses perspectiveECCO'24Year: 2024
Authors: Hartmann, P.(1)*;Zemke, J.(2);Plachta-Danielzik, S.(3,4);Steiner, I.M.(5);Pohlschneider, D.(6);Urzica, E.(6);Tappe, U.(7);Schreiber, S.(8);Steinkat, N.(9);Langbrandtner, J.(10,11);Hüppe, A.(12);Stargardt, T.(13);Bokemeyer, B.(6,14);
(1)Gastroenterology Practice, Department of Gastroenterology, Minden, Germany;(2)Gastroenterology Practice, Department of Gastroenterology, Herne, Germany;(3)Competence Network IBD, IBD Oganisation, Kiel, Germany;(4)Christian-Albrechts University- Kiel, Institute of Human Nutrition and Food Science, Kiel, Germany;(5)University of Hamburg, Center of Health Economics, Hamburg, Germany;(6)Competence Network IBD, IBD Organisation, Kiel, Germany;(7)Gastroenterology Practice, Department of Gastroenterology, Hamm, Germany;(8)University Hospital Schleswig-Holstein- Campus Kiel, Clinic of General Internal Medicine, Kiel, Germany;(9)Techniker Krankenkasse, Health insurance, Hamburg, Germany;(10)University of Lübeck, Institute of Social Medicine and Epidemiology, Lübeck, Germany;(11)University of Lübeck, Center for Population Medicine and Health Services Research, Lübeck, Germany;(12)University of Lübeck, Institute of Social Medicine and Epidemiology-, Lübeck, Germany;(13)University of Hamburg, Hamburg Center for Health Economics, Hamburg, Germany;(14)University Hospital Schleswig-Holstein- Campus Kiel, of General Internal Medicine I, Kiel, Germany;
N03: Flexibility & Accessibility, e-Literacy, Resourcing and The Human Factor: Early Lessons from EIBD, a UK Qualitative Interview StudyECCO'24Year: 2024
Authors: Avery, P.(1)*;Kemp, K.(2);Dibley, L.(3);Green, S.(4);
(1)Bournemouth University, Nursing Science, Bournemouth, United Kingdom;(2)Manchester Royal Infirmary, Gastroenterology IBD, Manchester, United Kingdom;(3)The Univerisity of Greenwich, Centre for Chronic Illness and Ageing, London, United Kingdom;(4)Bournemouth University, Nursing Sciences, Bournemouth, United Kingdom;
N04: Impact of phase angle on nutritional assessment and disease activity in patients with Ulcerative ColitisECCO'24Year: 2024
Authors: Bueno Hernández, N.(1)*;Viridiana Montsserrat, M.M.(2);Javier Ivanovychs , C.R.(3);Francisca , M.S.(4);Jorge , D.L.R.(5);
(1)General Hospital of Mexico Dr. Eduardo Licega, Research division, Mexico City-, Mexico;(2)General Hospital of Mexico, Infammatory Bowel Disease Clinic, Mexico City, Mexico;(3)Centro Medico La Raza, Gastroenterología, Mexico City, Mexico;(4)Centro Médico La Raza, Gastroenterologia, Mexico City, Mexico;(5)General Hospital of Mexico, Inflammatory Bowel Disease Clinic, Mexico City, Mexico;
N06: Self-care in patients affected by inflammatory bowel disease: SELF-IBD observational study in a single centerECCO'24Year: 2024
Authors: Napolitano, D.(1,2)*;Schiavoni, E.(2);Amatucci, V.(2);Monaci, A.(1,3);Martella, P.(1,3);Orgiana, N.(4);Benini, V.(2);Di Massimo, A.(2);Turchini, L.(2);Giordano, L.N.(2);Conticelli, C.(2);Pettinari, V.(2);De Vito, A.(2);Virone, C.(2);Lorusso, A.(2);Fanali, C.(2);Ribaudi, E.(2);Bernabei, T.(2);Gasbarrini, A.(2,5);Scaldaferri, F.(2,5);Cocchieri, A.(5);
(1)Tor Vergata University, Tor Vergata University, Rome, Italy;(2)Fondazione Policlinico Gemelli IRCCS, Cemad, Rome, Italy;(3)Fondazione Policlinico Gemelli IRCCS, Ticc, Rome, Italy;(4)Fondazione Policlinico Gemelli IRCCS, Cut, Rome, Italy;(5)Università Cattolica del Sacro Cuore, Università Cattolica del Sacro Cuore, Rome, Italy;
N07: JAKne: JAK inhibitor associated acne, a real-life single-center experience.ECCO'24Year: 2024
Authors: De Dycker, E.(1)*;Vermeire, S.(1);Ferrante, M.(1);Lambrechts, T.(1);Paps, A.(1);Geens, P.(1);Loddewijkx, E.(1);Sabino, J.(1);Hillary, T.(2);Verstockt, B.(1);
(1)University Hospitals Leuven Belgium, Department of Gastroenterology and Hepatology, Leuven, Belgium;(2)University Hospitals Leuven Belgium, Department of Dermatology, Leuven, Belgium;
